CCDC134 controls TLR biogenesis through the ER chaperone Gp96
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20240825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Léa Bernaleau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunobiology, University of Lausanne, Epalinges, Switzerland. Hauptthemen laut MEDLINE: Endoplasmic Reticulum, Membrane Glycoproteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Fondation Pierre Mercier pour la science, European Molecular Biology Organization.
Abstract (Originalsprache)
Toll-like receptors (TLRs) are central to initiate immune responses against invading pathogens. To ensure host defense while avoiding aberrant activation leading to pathogenic inflammation and autoimmune diseases, TLRs are tightly controlled by multilevel regulatory mechanisms. Through a loss-of-function genetic screen in a reporter cell line engineered to undergo cell death upon TLR7-induced IRF5 activation, we identified here CCDC134 as an essential factor for TLR responses. CCDC134 deficiency impaired endolysosomal TLR-induced NF-κB, MAPK, and IRF5 activation, as well as downstream production of proinflammatory cytokines and type I interferons. We further demonstrated that CCDC134 is an endoplasmic reticulum (ER)–resident interactor of Gp96 (HSP90B1/Grp94), an ER chaperone essential for folding and trafficking of plasma membrane and endolysosomal TLRs. CCDC134 controlled Gp96 stability as its loss led to Gp96 hyperglycosylation and ER-associated protein degradation (ERAD)-mediated clearance. Accordingly, CCDC134 deficiency impaired the folding, maturation, and trafficking of TLRs, resulting in blunted inflammatory responses upon stimulation. Altogether, this study reveals CCDC134 as a central regulator of the chaperone Gp96, thereby controlling TLR biogenesis and responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunobiology, University of Lausanne, Epalinges, Switzerland.
- Max Planck Institute for Infection Biology , Berlin, Germany.
ORCID-Profile: Léa Bernaleau, Michaela Drobek, Fenja Blank, Philipp Walch, Maeva Delacrétaz, Ales Drobek, Marta Monguió-Tortajada, Petr Broz, Olivia Majer, Manuele Rebsamen
Förderung
- Swiss National Science Foundation
- Fondation Pierre Mercier pour la science
- European Molecular Biology Organization
Zitieren
APA
Bernaleau, L., Drobek, M., Blank, F., Walch, P., Delacrétaz, M., Drobek, A., Monguió-Tortajada, M., Broz, P., Majer, O., & Rebsamen, M. (2025). CCDC134 controls TLR biogenesis through the ER chaperone Gp96. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20240825
Vancouver
Bernaleau L, Drobek M, Blank F, Walch P, Delacrétaz M, Drobek A, et al. CCDC134 controls TLR biogenesis through the ER chaperone Gp96. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20240825
BibTeX
@article{Bernaleau2025,
author = {Bernaleau, Léa and Drobek, Michaela and Blank, Fenja and Walch, Philipp and Delacrétaz, Maeva and Drobek, Ales and Monguió-Tortajada, Marta and Broz, Petr and Majer, Olivia and Rebsamen, Manuele},
title = {CCDC134 controls TLR biogenesis through the ER chaperone Gp96},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20240825}
}
EUVIMED